Skip to main content

Table 1 (abstract A59). Medication Use Documented at Baseline Visit of Patients with SLE and Related Conditions in the CARRA Registry (n=380)

From: Proceedings of the 2019 Childhood Arthritis and Rheumatology Research Alliance (CARRA) Annual Scientific Meeting

Medication n (%)
Hydroxychloroquine 336 (88%)
Oral Prednisone 232 (61%)
Mycophenolate mofetil/Mycophenolic Acid 161 (42%)
Methotrexate 63 (17%)
Cyclophosphamide 49 (13%)
Azathioprine 50 (13%)
Rituximab 47 (12%)
Belimumab 4 (1%)